COVID-19 vaccines and mental distress

The COVID-19 pandemic brought about large increases in mental distress. The uptake of COVID-19 vaccines is expected to significantly reduce health risks, improve economic and social outcomes, with potential benefits to mental health. To examine short-term changes in mental distress following the rec...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:PloS one Ročník 16; číslo 9; s. e0256406
Hlavní autoři: Perez-Arce, Francisco, Angrisani, Marco, Bennett, Daniel, Darling, Jill, Kapteyn, Arie, Thomas, Kyla
Médium: Journal Article
Jazyk:angličtina
Vydáno: United States Public Library of Science 08.09.2021
Public Library of Science (PLoS)
Témata:
Anxiety
Biology and Life Sciences
Care and treatment
Coronaviruses
COVID-19
COVID-19 - immunology
COVID-19 - psychology
COVID-19 vaccines
COVID-19 Vaccines - immunology
Epidemics
Female
Health risks
Humans
Internet access
Male
Medicine and Health Sciences
Mental Disorders - psychology
Mental health
Mental Health - statistics & numerical data
Middle Aged
Pandemics
Pandemics - prevention & control
Patient Health Questionnaire - statistics & numerical data
Polls & surveys
Psychological aspects
Psychological Distress
Reduction
Regression analysis
Regression models
Research and Analysis Methods
SARS-CoV-2 - immunology
Self Report - statistics & numerical data
Social research
Social Sciences
Statistical analysis
Surveys and Questionnaires - statistics & numerical data
Vaccines
Variables
United States
Los Angeles California
United States > US
California
ISSN:1932-6203, 1932-6203
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The COVID-19 pandemic brought about large increases in mental distress. The uptake of COVID-19 vaccines is expected to significantly reduce health risks, improve economic and social outcomes, with potential benefits to mental health. To examine short-term changes in mental distress following the receipt of the first dose of the COVID-19 vaccine. Participants included 8,003 adults from the address-based sampled, nationally representative Understanding America Study (UAS), surveyed at regular intervals between March 10, 2020, and March 31, 2021 who completed at least two waves of the survey. Respondents answered questions about COVID-19 vaccine status and self-reported mental distress as measured with the four-item Patient Health Questionnaire (PHQ-4). Fixed-effects regression models were used to identify the change in PHQ-4 scores and categorical indicators of mental distress resulting from the application of the first dose of the COVID-19 vaccine. People who were vaccinated between December 2020 and March 2021 reported decreased mental distress levels in the surveys conducted after receiving the first dose. The fixed-effects estimates show an average effect of receiving the vaccine equivalent to 4% of the standard deviation of PHQ-4 scores (p-value<0.01), a reduction in 1 percentage point (4% reduction from the baseline level) in the probability of being at least mildly depressed, and of 0.7 percentage points (15% reduction from the baseline level) in the probability of being severely depressed (p-value = 0.06). Getting the first dose of COVID-19 resulted in significant improvements in mental health, beyond improvements already achieved since mental distress peaked in the spring of 2020.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0256406